Literature DB >> 22194443

Epigenomic program of Barrett's-associated neoplastic progression reveals possible involvement of insulin signaling pathways.

Rachana Agarwal, Zhe Jin, Jian Yang, Yuriko Mori, Jee Hoon Song, Sahil Kumar, Masato Sato, Yulan Cheng, Alexandru V Olaru, John M Abraham, Amit Verma, Stephen J Meltzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22194443      PMCID： PMC3688264          DOI： 10.1530/ERC-11-0364

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


× No keyword cloud information.
  5 in total

Review 1.  The insulin-like growth factor signaling pathway as a target for treatment of colorectal carcinoma.

Authors:  Gideon P Ewing; Laura W Goff
Journal:  Clin Colorectal Cancer       Date:  2010-10       Impact factor: 4.481

2.  JunD protects cells from p53-dependent senescence and apoptosis.

Authors:  J B Weitzman; L Fiette; K Matsuo; M Yaniv
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

3.  Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.

Authors:  M Toyota; C Ho; N Ahuja; K W Jair; Q Li; M Ohe-Toyota; S B Baylin; J P Issa
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

4.  Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.

Authors:  Karsten Schulmann; Anca Sterian; Agnes Berki; Jing Yin; Fumiaki Sato; Yan Xu; Andreea Olaru; Suna Wang; Yuriko Mori; Elena Deacu; James Hamilton; Takatsugu Kan; Mark J Krasna; David G Beer; Margaret S Pepe; John M Abraham; Ziding Feng; Wolff Schmiegel; Bruce D Greenwald; Stephen J Meltzer
Journal:  Oncogene       Date:  2005-06-09       Impact factor: 9.867

5.  Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements.

Authors:  Andishe Attarbaschi; Markus Pisecker; Andrea Inthal; Georg Mann; Dasa Janousek; Michael Dworzak; Ulrike Pötschger; Reinhard Ullmann; Martin Schrappe; Helmut Gadner; Oskar A Haas; Renate Panzer-Grümayer; Sabine Strehl
Journal:  Br J Haematol       Date:  2009-10-11       Impact factor: 6.998
  5 in total
  7 in total

Review 1.  Epigenetic biomarkers in esophageal cancer.

Authors:  Andrew M Kaz; William M Grady
Journal:  Cancer Lett       Date:  2012-03-07       Impact factor: 8.679

2.  Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study.

Authors:  Jose M Garcia; Andres E Splenser; Jennifer Kramer; Abeer Alsarraj; Stephanie Fitzgerald; David Ramsey; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-15       Impact factor: 11.382

3.  Global changes in gene expression of Barrett's esophagus compared to normal squamous esophagus and gastric cardia tissues.

Authors:  Paula L Hyland; Nan Hu; Melissa Rotunno; Hua Su; Chaoyu Wang; Lemin Wang; Ruth M Pfeiffer; Barbara Gherman; Carol Giffen; Cathy Dykes; Sanford M Dawsey; Christian C Abnet; Kathryn M Johnson; Ruben D Acosta; Patrick E Young; Brooks D Cash; Philip R Taylor
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

4.  Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma.

Authors:  Jia-Jie Hao; De-Chen Lin; Huy Q Dinh; Anand Mayakonda; Yan-Yi Jiang; Chen Chang; Ye Jiang; Chen-Chen Lu; Zhi-Zhou Shi; Xin Xu; Yu Zhang; Yan Cai; Jin-Wu Wang; Qi-Min Zhan; Wen-Qiang Wei; Benjamin P Berman; Ming-Rong Wang; H Phillip Koeffler
Journal:  Nat Genet       Date:  2016-10-17       Impact factor: 38.330

5.  Temporal evolution in caveolin 1 methylation levels during human esophageal carcinogenesis.

Authors:  Zhe Jin; Liang Wang; Ziyi Cao; Yulan Cheng; Yan Gao; Xianling Feng; Si Chen; Huimin Yu; Wenjing Wu; Zhenfu Zhao; Ming Dong; Xiaojing Zhang; Jie Liu; Xinmin Fan; Yuriko Mori; Stephen J Meltzer
Journal:  BMC Cancer       Date:  2014-05-20       Impact factor: 4.430

6.  A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma.

Authors:  Tom Nieto; Claire L Tomlinson; Janine Dretzke; Susan Bayliss; Malcolm James Price; Mark Dilworth; Andrew D Beggs; Olga Tucker
Journal:  BMJ Open       Date:  2018-06-30       Impact factor: 2.692

7.  Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer.

Authors:  Mark P Dilworth; Tom Nieto; Jo D Stockton; Celina M Whalley; Louise Tee; Jonathan D James; Fergus Noble; Tim J Underwood; Michael T Hallissey; Rahul Hejmadi; Nigel Trudgill; Olga Tucker; Andrew D Beggs
Journal:  Ann Surg       Date:  2019-03       Impact factor: 12.969
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.